Ekso Bionics Common Stock 

$11.8
51
+$0.01+0.08% Monday 20:00

Statistics

Day High
11.8
Day Low
10.56
52W High
12.95
52W Low
2.82
Volume
95,135
Avg. Volume
-
Mkt Cap
30.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.04
-1.38
-0.72
-0.06
Expected EPS
-0.0626
Actual EPS
N/A

Financials

-63.21%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
35.85MRevenue
-22.66MNet Income

Analyst Ratings

0Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKSO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Resmed
RMD
Mkt Cap29.87B
ResMed Inc. competes in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, a field closely related to Ekso Bionics' focus on medical devices for physical assistance.
Community Health Systems
CYH
Mkt Cap401.61M
Community Health Systems, Inc. operates hospitals and healthcare facilities, which could be potential users of Ekso Bionics' medical devices, making them indirect competitors in the healthcare solutions market.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Ekso Bionics in the broader market for medical devices that aid mobility.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew plc designs, manufactures, and markets medical devices for the orthopedic market, competing with Ekso Bionics in the development of technologies for physical rehabilitation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc specializes in medical technologies, services, and solutions, including those for spinal and musculoskeletal conditions, making it a competitor in the medical device market alongside Ekso Bionics.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation specializes in medical technologies, including orthopedics, making it a competitor in the market for devices that support physical mobility and rehabilitation.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical, Inc. focuses on musculoskeletal solutions, directly competing with Ekso Bionics in the development and marketing of medical devices aimed at improving physical mobility.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing indirectly with Ekson Bionics by offering alternative solutions for patient care.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. specializes in medical devices for diagnostics, surgery, and women's health, indirectly competing with Ekso Bionics by providing alternative medical technologies that could be used in patient rehabilitation and care.

About

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Show more...
CEO
Mr. Scott G. Davis
Employees
61
Country
United States
ISIN
US2826444000

Listings

0 Comments

Share your thoughts

FAQ

What is Ekso Bionics Common Stock stock price today?
The current price of EKSO is $11.8 USD — it has increased by +0.08% in the past 24 hours. Watch Ekso Bionics Common Stock stock price performance more closely on the chart.
What is Ekso Bionics Common Stock stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ekso Bionics Common Stock stocks are traded under the ticker EKSO.
Is Ekso Bionics Common Stock stock price growing?
EKSO stock has risen by +3.15% compared to the previous week, the month change is a +21.03% rise, over the last year Ekso Bionics Common Stock has showed a +81.68% increase.
What is Ekso Bionics Common Stock market cap?
Today Ekso Bionics Common Stock has the market capitalization of 30.95M
When is the next Ekso Bionics Common Stock earnings date?
Ekso Bionics Common Stock is going to release the next earnings report on August 03, 2026.
What were Ekso Bionics Common Stock earnings last quarter?
EKSO earnings for the last quarter are -2.04 USD per share, whereas the estimation was -0.19 USD resulting in a -973.68% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ekso Bionics Common Stock revenue for the last year?
Ekso Bionics Common Stock revenue for the last year amounts to 35.85M USD.
What is Ekso Bionics Common Stock net income for the last year?
EKSO net income for the last year is -22.66M USD.
How many employees does Ekso Bionics Common Stock have?
As of May 06, 2026, the company has 61 employees.
In which sector is Ekso Bionics Common Stock located?
Ekso Bionics Common Stock operates in the Health & Wellness sector.
When did Ekso Bionics Common Stock complete a stock split?
The last stock split for Ekso Bionics Common Stock was on June 02, 2025 with a ratio of 1:15.
Where is Ekso Bionics Common Stock headquartered?
Ekso Bionics Common Stock is headquartered in San Rafael, United States.